Platelet Fc Receptor
Open Access
- 1 April 1981
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 67 (4) , 1064-1071
- https://doi.org/10.1172/jci110118
Abstract
The platelet Fc receptor, a membrane receptor for immune complexes or aggregated immunoglobulin (Ig)G, was compared in normal and myeloproliferative platelets. Washed platelets from 11 normal donors and 27 patients were incubated with fluorescein-conjugated ovalbumin-anti-ovalbumin complexes and examined by phase and fluorescence microscopy. Only 3.2±1% of the normal platelets stained, whereas 76±16% of the myeloproliferative platelets stained with the immune complex. The fluorescent staining was mediated by a platelet Fc receptor, as shown by the absence of platelet staining with immune complex containing antibody preincubated with Staphylococcal protein A to block the Fc region. In addition, no staining occurred with antigen or antibody alone or after preincubation of platelets with aggregated IgG. Platelets from normal or myeloproliferative donors did not stain with the immune complexes when the incubation was performed in plasma. The increased expression of Fc receptors on myeloproliferative platelets was corroborated by studies of [14C]serotonin release by immune complexes or aggregated IgG in 8 patients and 17 normal donors. Serotonin uptake was similar in both groups. Myeloproliferative platelets released significantly more serotonin than normal platelets at each concentration of immune complex or aggregated IgG; in addition, myeloproliferative platelets released serotonin in response to much smaller concentrations of immune complex or aggregated IgG. [14C]Serotonin release by myeloproliferative platelets was not increased above that of normal platelets when thrombin was used as the stimulus. The results were independent of patient age, sex, therapy, hematocrit, or platelet size. Interaction of circulating immune complexes with platelets bearing increased Fc receptors may contribute to the abnormal hemostasis associated with the myeloproliferative syndromes.This publication has 28 references indexed in Scilit:
- Characterization of the Platelet Prostaglandin D2 ReceptorJournal of Clinical Investigation, 1979
- Hormonal regulation of peptide receptors and target cell responsesNature, 1979
- Human megakaryocytes. I. Characterization of the membrane and cytoplasmic components of isolated marrow megakaryocytes.The Journal of Experimental Medicine, 1979
- Glucocorticoids inhibit expression of Fc receptors on the human granulocytic cell line HL-60Nature, 1979
- Platelet Function in Essential ThrombocythemiaNew England Journal of Medicine, 1978
- IMMUNE COMPLEXES IN MYELOPROLIFERATIVE DISORDERSThe Lancet, 1977
- The Problem of Platelet AutoantibodiesVox Sanguinis, 1977
- Immunoinhibition of ristocetin-induced platelet aggregation.Journal of Clinical Investigation, 1977
- Release of Serotonin from Human Platelets Induced by Aggregated Immunoglobulins of Different Classes and SubclassesJournal of Clinical Investigation, 1973
- THE NATURAL HISTORY OF AGNOGENIC MYELOID METAPLASIA (AMM) AND A CRITICAL EVALUATION OF ITS RELATIONSHIP WITH THE MYELOPROLIFERATIVE SYNDROMEMedicine, 1971